Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy.
Oncotarget
; 5(16): 7198-211, 2014 Aug 30.
Article
in En
| MEDLINE
| ID: mdl-25216532
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Fusion Proteins, bcr-abl
/
Capsid Proteins
/
Protein Kinase Inhibitors
Limits:
Animals
/
Humans
Language:
En
Journal:
Oncotarget
Year:
2014
Document type:
Article
Country of publication: